A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C

NCT03420768 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Cirrhosis
Liver Fibrosis

Interventions

DRUG: BMS-986263
OTHER: Placebo

Sponsor

Bristol-Myers Squibb